Reversible envelope effects during and after killing of Escherichia coli w by a highly-purified rabbit polymorpho-nuclear leukocyte fraction.
The effects of a highly-purified, potently bactericidal fraction from rabbit polymorphonuclear leukocytes on the envelope of Escherichia coli (W) have been examined. This leukocyte fraction has equally enriched bactericidal, permeability-increasing and phospholipase A2 activities, and is essentially devoid of lysozyme, myeloperoxidase and protease activities (Weiss, J., Franson, R.C., Beckerdite, S., Schmeidler, K. and Elsbach, P. (1975) J. Clin. Invest. 55, 33-42). Rapid killing of E. coli by this fraction is accompanied by two almost immediate alterations in the bacterial envelope: (1) a discrete increase in envelope permeability (measured by inhibition of bacterial leucine incorporation by normally impermeant actinomycin D), and, (2) hydrolysis of 14C-labeled fatty acid-prelabeled E. coli phospholipids. Both envelope effects are promptly reversed during further incubation at 37 degrees C, But not at 0 degrees C, with 40 mM Mg2+. Reversal is also produced by Ca2+ (40 mM) and trypsin (200 mug/ml), but 200 mM K+ causes only partial recovery and Na+ and hyperosmolar sucrose are ineffective. Upon addition of Mg2+, phospholipid degradation ceases abruptly and the labeled products of hydrolysis (free fatty acids and lysocompounds) disappear with a corresponding reaccumulation of radioactive diacylphosphatides. The time course of resynthesis of phospholipids coincides with that of restoration of the permeability barrier. Higher concentrations of the leukocyte fraction and prolonged incubation increase both the extent of phospholipid degradation and the time required for reversal of both envelope effects. These findings suggest that both the initiation of the increased permeability and its reversal are linked to respectively the breakdown and resynthesis of major E. coli membrane phospholipids, and thus depend on the fact that the biochemical apparatus of E. coli remains capable of biosynthesis despite loss of viability. Treatment of E. coli, exposed to the leukocyte fraction, with albumin results in extracellular sequestration of the products of hydrolysis and also restores the permeability barrier to actinomycin D, suggesting that the accumulation of lytic products of lipid hydrolysis within the bacterial envelope, rather than the loss of phospholipids per se, causes increased permeability Whereas the effects on the envelope are reversible as long as 2 h after nearly complete loss of ability to multiply by E. coli, the effect on bacterial multiplication is irreversible within 5 min.
D000818:Animals; D001798:Blood Proteins / Q000502:physiology*; D002118:Calcium / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D002463:Cell Membrane Permeability / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003609:Dactinomycin / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects / Q000378:metabolism* / Q000648:ultrastructure; D007700:Kinetics; D007930:Leucine / Q000378:metabolism; D008274:Magnesium / Q000494:pharmacology; D008854:Microscopy, Electron; D009504:Neutrophils / Q000502:physiology*; D010743:Phospholipids / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D014176:Protein Biosynthesis / Q000187:drug effects; D011817:Rabbits; D012964:Sodium / Q000494:pharmacology; D013395:Sucrose / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology
D001798:Blood Proteins; D010743:Phospholipids; D003609:Dactinomycin; D013395:Sucrose; D012964:Sodium; D014357:Trypsin; D007930:Leucine; D008274:Magnesium; D011188:Potassium; D002118:Calcium